.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Argus Health
Cerilliant
US Department of Justice
Baxter
Novartis
Johnson and Johnson
Teva
Healthtrust

Generated: September 23, 2017

DrugPatentWatch Database Preview

Sonidegib phosphate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sonidegib phosphate and what is the scope of sonidegib phosphate freedom to operate?

Sonidegib phosphate
is the generic ingredient in one branded drug marketed by Sun Pharma Global and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sonidegib phosphate has ninety patent family members in forty-five countries.

There are two drug master file entries for sonidegib phosphate. One supplier is listed for this compound.

Summary for Generic Name: sonidegib phosphate

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Clinical Trials: see list797
Drug Prices:see low prices
DailyMed Link:sonidegib phosphate at DailyMed

Pharmacology for Ingredient: sonidegib phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sonidegib phosphate

Country Document Number Estimated Expiration
Denmark2342198► Subscribe
Cuba23760► Subscribe
Japan5603308► Subscribe
Taiwan200811132► Subscribe
World Intellectual Property Organization (WIPO)2007131201► Subscribe
Russian Federation2413718► Subscribe
Dominican RepublicP2011000082► Subscribe
South Korea101129088► Subscribe
Peru02922011► Subscribe
Cyprus1114471► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SONIDEGIB PHOSPHATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015051Lithuania► SubscribePRODUCT NAME: SONIDEGIBUM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
C0077France► SubscribePRODUCT NAME: SONIDEGIB OU SEL,HYDRATE,OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1030 20150818
90062-4Sweden► SubscribePRODUCT NAME: SONIDEGIB OR A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF; REG. NO/DATE: EU/1/15/1030 20150818
2016000001Germany► SubscribePRODUCT NAME: SONIDEGIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ, HYDRAT ODER SOLVAT HIERVON; REGISTRATION NO/DATE: EU/1/15/1030 20150814
2015 00057Denmark► SubscribePRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
2015 00057Denmark► SubscribePRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
0790Netherlands► SubscribePRODUCT NAME: SONIDEGIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, HYDRAAT OF SOLVAAT; REGISTRATION NO/DATE: EU/1/15/1030 (C(2015)5890) 20150818
5 5026-2015Slovakia► SubscribePRODUCT NAME: SONIDEGIB VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
883Luxembourg► SubscribePRODUCT NAME: SONIDEGIB OU UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE; FIRST REGISTRATION: 20150818
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Covington
Dow
Deloitte
Federal Trade Commission
Mallinckrodt
Cipla
Healthtrust
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot